Health Care/Hospital
VISTA Eye Specialist Achieves International Recognition at European Congress
PETALING JAYA, Malaysia, Oct. 11, 2023 /PRNewswire/ -- Last September, VISTA Eye Specialist proudly marked its presence at the prestigious European Society of Cataract and Refractive Surgery (ESCRS) Symposium and Congress inVienna, Austria. This event, the second participation since the onset of ...
JUNG KWAN JANG launches student-specialized brand I.PASS for physical strength, immunity, and memory all at once
- The essential item that Korean parents with high enthusiasm over education provide for their children SEOUL, South Korea, Oct. 11, 2023 /PRNewswire/ -- I.PASS, a student-specialized brand that was renewed and launched through JUNG KWAN JANG red ginseng of KGC (Korea Ginseng Corp.), is a health...
EADV Congress: Non-melanoma skin cancer killing more people than melanoma, new study finds
BERLIN, Oct. 11, 2023 /PRNewswire/ -- Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the EADV Congress 2023 has found. Researchers also believe that NMSC is underreported and that the...
SAFETYscan47: A Valuable Component in Revolutionizing Chemical Risk Assessments for Global Health and Safety
SAN DIEGO, Oct. 10, 2023 /PRNewswire/ -- Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, today announced its SAFETYscan®47 platform as a New Approach Methodology (NAM), part of a standardized framework aiming to revolutionize chemical risk a...
Lunit to Showcase 9 AI-based Research Results at ESMO 2023
- 9 abstracts accepted by the ESMO annual meeting - unveiling insights into cancer analysis, immunotherapy response, and predictive biomarkers at ESMO 2023 SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics an...
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503
- Among 14 efficacy-evaluable patients in the ongoing Phase 1 study, one achieved a complete response, one had partial response and two unconfirmed partial responses; maximum tolerated dose not yet reached - Patent rights secured for TJ-L14B/ABL503 in Eurasia until 2039 ROCKVILLE, ...
Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper published in 'Allergy' DAVOS, Switzerland, Oct. 10, 2023 /PRNewswire/ -- The revision of the current allergic disease nomenclature based on symptoms and organ dysfunction has been l...
GenFleet Starts Phase Ib/II Trial of GFH009 (Highly Selective CDK9 Inhibitor) Treating Patients with Relapsed/Refractory Peripheral T-cell Lymphomas (PTCL)
SHANGHAI, Oct. 10, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the first subject was dosed in a phase Ib/II trial of GFH009 (a highly selective CDK9 inhibitor) treating relapsed/r...
Gates Foundation Celebrates 20 Years of "Grand Challenges" With New Investments and a Call to Make R&D Breakthroughs Available More Quickly and Equitably
Commitments focus on advancing equitable access to artificial intelligence (AI) and vaccines,and catalyzing innovations that address women's health SEATTLE and DAKAR, Senegal, Oct. 10, 2023 /PRNewswire/ -- A slate of new initiatives to support locally led innovation was announced today inDakar b...
Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-- STX-721 is characterized by high selectivity and a potentially best-in-class profile -- -- Scorpion's second program to enter clinical development this year -- -- One of two EGFR programs being developed with Pierre Fabre Laboratories -- BOSTON and CASTRES, France, Oct. 10, 2023 /PRNewswire/...
Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health
Global Think Tanks and Collaboration to Drive Innovation and Empowerment in Women's Health SAN ANTONIO, Oct. 10, 2023 /PRNewswire/ -- Frost & Sullivan, a renowned leader in fostering innovation and driving transformative change, proudly announces the launch of its groundbreaking"EmpowerHer" Grow...
GC Biopharma Signs Power Purchase Agreement with SK E&S
YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced on today that it has signed Power Purchase Agreement (PPA) with SK E&S Co., Ltd onOctober 5th at its Ochang Plant. PPA is an electricity trading contract signed directly between a power generator and a customer c...
Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre
TAIZHOU, China, Oct. 10, 2023 /PRNewswire/ -- On October 8, 2023, Dr. Deckster Tonny SAVADYE, CEO of Zimbabwe NBA, and Dr.Yang Yili, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre(ICGEB), visited Recbio. Dr. SAVADYE and his team conducted an on-the-s...
Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace
SINGAPORE, Oct. 10, 2023 /PRNewswire/ -- Fullerton Health & Connections MindHealth are pleased to announce the release of a Healthcare Brief that addresses critical challenges surrounding mental health in the workplace. Titled "A Framework for Action: Enhancing Mental Health in the Workplace", th...
Xinhua Silk Road: Chinese dairy giant Yili shares whole-lifecycle nutrition and health innovative practices at Growth Asia Summit 2023 in Singapore
BEIJING, Oct. 10, 2023 /PRNewswire/ -- Chinese dairy giant Inner Mongolia
Mental Health is the Foundation for Learning
Education Cannot Wait Executive Director Yasmine Sherif Statement on World Mental Health Day NEW YORK, Oct. 10, 2023 /PRNewswire/ -- Millions of school-aged children, adolescents and their teachers in countries of brutal conflicts, devastating climate disasters and refuge are calling out for our...
CanariaBio and Hikma announce the signing of distribution and license agreement for oregovomab in MENA Region
SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ -- CanariaBio Inc. and Hikma MENA FZE, part of Hikma Pharmaceuticals PLC (Hikma), today announced the signing of distribution and license agreement for oregovomab in theMiddle East andNorth Africa (MENA) region. "We are thrilled to partner with Hi...
AffaMed Technologies Announces Licensing of EVOLUX®- a novel extended monofocal intraocular lens (IOL) designed to provide better intermediate vision and equivalent distance vision when compared to a standard monofocal IOL
Expands Portfolio of Cataract Surgery Solutions for Patients in Greater China to New Extended Monofocal Segment AffaMed Therapeutics and SIFI Leadership Celebrate Strong Progress of the AffaMed Technologies Joint-Venture BEIJING, Oct. 10, 2023 /PRNewswire/ -- AffaMed Technologies ("AffaMed"), a ...
Kaneka Files Patent Infringement Lawsuit Against CoCrystal
TOKYO, Oct. 10, 2023 /PRNewswire/ -- On October 5, 2023, Kaneka Corporation filed a lawsuit inthe United States District Court for the Eastern District of New York against Cocrystal Technology Co. Ltd. and Cocrystal Health Industry Co. Ltd. (collectively "CoCrystal") seeking an injunction and mon...
Dr. Ming H. Wu, Former Senior Vice President of Engineering at Edwards Lifesciences, Joins Medeologix as Board Member and Advisor
NEW TAIPEI CITY, Taiwan, Oct. 9, 2023 /PRNewswire/ -- Medeologix, a global
medical device contract development and manufacturing company known for its
one-stop shop service with engineering excellence, is pleased to announce that
Dr.Ming H. Wu has joined as a board member and advisor.
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00